AP-238

AP-238
Legal status
Legal status	UK: Under Psychoactive Substances Act; US: The DEA is not of the opinion that AP-237 and derivatives are Controlled Substances, or analogues thereof. ;
Identifiers
	IUPAC name 1-[(2R,6S)-2,6-dimethyl-4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]propan-1-one;
CAS Number	(racemic) 4204-01-7 (racemic) ; 140924-11-4 (2R,6S enantiomer);
PubChem CID	124389619;
ChemSpider	4941886;
UNII	N26WML8AR7;
Chemical and physical data
Formula	C18H26N2O
Molar mass	286.419 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCC(=O)N1[C@@H](CN(C[C@@H]1C)C/C=C/C2=CC=CC=C2)C;
	InChI InChI=1S/C18H26N2O/c1-4-18(21)20-15(2)13-19(14-16(20)3)12-8-11-17-9-6-5-7-10-17/h5-11,15-16H,4,12-14H2,1-3H3/b11-8+/t15-,16+; Key:JELNWDOXWGBBLO-QJBCGIKSSA-N;

AP-238 is an opioid designer drug related to drugs such as azaprocin and bucinnazine, with around the same potency as morphine.^[2] It was first discovered in Italy in the 1960s but was never marketed,^[3] subsequently appearing on the illicit market around 2020 and being detected in both Slovenia and the USA.^[4]^[5]

Quick Facts Legal status, Identifiers ...

Close

[2]

[3]

[4]

[5]

[1]

AP-238

See also

References

Wikiwand - on